Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Halldin

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
NIDA Research Monograph|January 1, 1989
Urinary elimination half-life of delta-1-tetrahydrocannabinol-7-oic acid in heavy marijuana users after smokingE K Johansson, L E Hollister, M M Halldin
Journal of Analytical Toxicology|November 1, 1996
A GC-MS study of three major acidic metabolites of delta 1-tetrahydrocannabinolM Szirmai, O Beck, N Stephansson, et al.
Biomedical Chromatography : BMC|January 1, 1989
Determination of delta 1-tetrahydrocannabinol in human fat biopsies from marihuana users by gas chromatography-mass spectrometryE Johansson, K Norén, J Sjövall, et al.
The Journal of Pharmacy and Pharmacology|May 1, 1988
Prolonged apparent half-life of delta 1-tetrahydrocannabinol in plasma of chronic marijuana usersE Johansson, S Agurell, L E Hollister, et al.
Biomedical & Environmental Mass Spectrometry|June 1, 1986
Unexpected adduct ion formation under chemical ionization conditionsD G Musson, M M Halldin, D Karashima, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|June 15, 2007
The metabolic syndrome: prevalence and association to leisure-time and work-related physical activity in 60-year-old men and womenM Halldin, M Rosell, U de Faire, et al.
Scandinavian Journal of Pain|July 25, 2025
Topically applied novel TRPV1 receptor antagonist, ACD440 Gel, reduces temperature-evoked pain in patients with peripheral neuropathic pain with sensory hypersensitivity, a randomized, double-blind, placebo-controlled, crossover studyAdriana Miclescu, Rolf Karlsten, Ingrid Lönnstedt, et al.
British Journal of Anaesthesia|February 1, 1995
CSF and plasma pharmacokinetics of the NMDA receptor antagonist CPP after intrathecal, extradural and i.v. administration in anaesthetized pigsJ D Kristensen, P Hartvig, R Karlsten, et al.
Arzneimittel-Forschung|January 1, 1982
Further urinary metabolites of delta 1-tetrahydrocannabinol in manM M Halldin, L K Andersson, M Widman, et al.
European Journal of Pain (London, England)|January 30, 2018
Preclinical characterization of three transient receptor potential vanilloid receptor 1 antagonists for early use in human intradermal microdose analgesic studiesE Sjögren, M M Halldin, O Stålberg, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
NIDA Research Monograph|January 1, 1989
Urinary elimination half-life of delta-1-tetrahydrocannabinol-7-oic acid in heavy marijuana users after smokingE K Johansson, L E Hollister, M M Halldin
Journal of Analytical Toxicology|November 1, 1996
A GC-MS study of three major acidic metabolites of delta 1-tetrahydrocannabinolM Szirmai, O Beck, N Stephansson, et al.
Biomedical Chromatography : BMC|January 1, 1989
Determination of delta 1-tetrahydrocannabinol in human fat biopsies from marihuana users by gas chromatography-mass spectrometryE Johansson, K Norén, J Sjövall, et al.
The Journal of Pharmacy and Pharmacology|May 1, 1988
Prolonged apparent half-life of delta 1-tetrahydrocannabinol in plasma of chronic marijuana usersE Johansson, S Agurell, L E Hollister, et al.
Biomedical & Environmental Mass Spectrometry|June 1, 1986
Unexpected adduct ion formation under chemical ionization conditionsD G Musson, M M Halldin, D Karashima, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|June 15, 2007
The metabolic syndrome: prevalence and association to leisure-time and work-related physical activity in 60-year-old men and womenM Halldin, M Rosell, U de Faire, et al.
Scandinavian Journal of Pain|July 25, 2025
Topically applied novel TRPV1 receptor antagonist, ACD440 Gel, reduces temperature-evoked pain in patients with peripheral neuropathic pain with sensory hypersensitivity, a randomized, double-blind, placebo-controlled, crossover studyAdriana Miclescu, Rolf Karlsten, Ingrid Lönnstedt, et al.
British Journal of Anaesthesia|February 1, 1995
CSF and plasma pharmacokinetics of the NMDA receptor antagonist CPP after intrathecal, extradural and i.v. administration in anaesthetized pigsJ D Kristensen, P Hartvig, R Karlsten, et al.
Arzneimittel-Forschung|January 1, 1982
Further urinary metabolites of delta 1-tetrahydrocannabinol in manM M Halldin, L K Andersson, M Widman, et al.
European Journal of Pain (London, England)|January 30, 2018
Preclinical characterization of three transient receptor potential vanilloid receptor 1 antagonists for early use in human intradermal microdose analgesic studiesE Sjögren, M M Halldin, O Stålberg, et al.
Pageof 5